Neurologic Imaging

Which Imaging Study Is Best for Suspected Adult Hypopituitarism?

·
Which Imaging Study Is Best for Suspected Adult Hypopituitarism?

A 48-year-old patient presents with several months of progressive fatigue, decreased libido, and unexplained weight gain. A comprehensive lab workup reveals low testosterone with inappropriately normal Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), alongside a low-normal free T4 with a non-elevated Thyroid-Stimulating Hormone (TSH). The clinical picture strongly suggests hypopituitarism, likely from a central cause. As the referring physician, you must now decide on the most effective initial imaging study to investigate the pituitary gland and surrounding structures. According to the American College of Radiology (ACR) Appropriateness Criteria, `MRI sella without and with IV contrast` is rated Usually appropriate for this exact clinical scenario, providing the highest diagnostic yield to guide subsequent management.

Who Fits This Clinical Scenario for Suspected Hypopituitarism?

This guidance applies specifically to adult patients with a new diagnosis or strong clinical suspicion of a hypofunctioning pituitary gland. The presentation may be rooted in a single hormone deficiency or multiple deficiencies, manifesting as:

  • Hypogonadotropic hypogonadism: Low sex hormones (testosterone/estrogen) without the expected compensatory rise in LH and FSH.
  • Central hypothyroidism: Low thyroid hormone levels with an inappropriately normal or low TSH.
  • Growth hormone (GH) deficiency: Often presenting in adults with vague symptoms like fatigue, altered body composition, and reduced quality of life.
  • Central adrenal insufficiency: Low cortisol with an inappropriately low Adrenocorticotropic Hormone (ACTH).
  • Panhypopituitarism: Deficiency of multiple or all anterior pituitary hormones.

It is crucial to distinguish this scenario from similar but distinct clinical presentations that require different imaging pathways. This workflow does not apply to:

  • Suspected hormone excess: Patients with symptoms of acromegaly, Cushing’s disease, or hyperprolactinemia fall under the hyperfunctioning pituitary adenoma ACR variant, which has its own specific imaging considerations.
  • Acute pituitary apoplexy: A patient presenting with a sudden, severe headache, visual disturbances, and altered consciousness requires an emergent evaluation for this neurosurgical emergency.
  • Diabetes insipidus: Patients whose primary symptoms are polyuria and polydipsia should be evaluated according to the specific ACR criteria for that condition.
  • Post-treatment surveillance: This guidance is for initial diagnostic imaging, not for routine follow-up after surgery or radiation for a known sellar mass.

What Diagnoses Are You Working Up in This Scenario?

The primary goal of imaging in suspected hypopituitarism is to identify a structural cause in the sellar or parasellar region. The differential diagnosis is broad, and MRI is uniquely capable of distinguishing among these possibilities.

Pituitary Adenoma
By far the most common cause of adult hypopituitarism is a pituitary adenoma, specifically a clinically non-functioning macroadenoma (>1 cm). These tumors do not secrete active hormones but cause symptoms through mass effect, compressing the normal pituitary gland, interfering with the pituitary stalk, or impinging on the optic chiasm. Their size and relationship to adjacent structures are critical for surgical planning.

Craniopharyngioma
Though often associated with childhood, craniopharyngiomas have a second incidence peak in adults between 50 and 70 years of age. These benign tumors arise from epithelial remnants of Rathke’s pouch and are often cystic, calcified, and adherent to surrounding neurovascular structures, making them a significant diagnostic consideration.

Empty Sella Syndrome
This condition occurs when the subarachnoid space extends into the sella turcica, compressing the pituitary gland against the sellar floor. Primary empty sella is often an incidental finding but can be associated with pituitary dysfunction. Secondary empty sella can result from surgery, radiation, or infarction of a pre-existing adenoma.

Inflammatory and Infiltrative Processes (Hypophysitis)
Less common but critical to diagnose, conditions like lymphocytic hypophysitis, sarcoidosis, or IgG4-related disease can cause pituitary inflammation, enlargement, and dysfunction. These often present with a characteristically thickened and enhancing pituitary stalk, a key finding on contrast-enhanced MRI.

Other Sellar and Parasellar Masses
Other pathologies that can mimic a pituitary adenoma and cause hypopituitarism include meningiomas, metastases to the pituitary gland (commonly from breast or lung cancer), or cysts such as a Rathke’s cleft cyst.

Why Is MRI of the Sella the Recommended Study for Hypopituitarism?

The ACR designates `MRI sella without and with IV contrast` as Usually appropriate because it offers the most comprehensive, non-invasive evaluation of the pituitary gland and its complex anatomical neighborhood. This multi-part examination is superior to other modalities for identifying the underlying cause of pituitary hypofunction.

The rationale for this recommendation is multi-faceted:

  • Superior Soft-Tissue Contrast: MRI provides unmatched detail of the pituitary gland, optic chiasm, cavernous sinuses, and hypothalamus. Pre-contrast T1- and T2-weighted images can delineate anatomy, identify cystic components (common in craniopharyngiomas and Rathke’s cleft cysts), and detect hemorrhage.
  • Essential Role of IV Contrast: The administration of a gadolinium-based contrast agent is crucial. The normal pituitary gland and stalk enhance brightly and early because they lack a blood-brain barrier. In contrast, most pituitary adenomas enhance more slowly and less intensely. This differential enhancement, especially on dynamic contrast-enhanced sequences, makes even small microadenomas conspicuous. Contrast is also vital for identifying inflammatory processes like hypophysitis and characterizing parasellar masses like meningiomas.
  • Safety Profile: MRI involves no ionizing radiation (0 mSv), a significant advantage over CT, especially in patients who may require future surveillance imaging.

Why are other studies rated lower for this scenario?

  • `CT sella with IV contrast` is rated May be appropriate. While it is a viable alternative if MRI is absolutely contraindicated (e.g., incompatible implanted device) or unavailable, its soft-tissue resolution is significantly inferior. CT is better at detecting calcifications (useful for craniopharyngiomas) and assessing bony erosion of the sella, but it is less sensitive for small adenomas and inflammatory conditions. It also involves a moderate dose of ionizing radiation (☢☢☢ 1-10 mSv).
  • `Radiography sella` is rated Usually not appropriate. This is an obsolete test for this indication. It can only show gross changes to the bony sella turcica and provides no information about the pituitary gland itself, making it diagnostically insufficient.

In cases where a patient has a contraindication to gadolinium, an `MRI sella without IV contrast` is also rated Usually appropriate. While this protocol sacrifices some diagnostic information, particularly for smaller lesions and inflammatory disease, it can still reliably identify macroadenomas, empty sella, and large cysts.

What’s Next After MRI of the Sella? Downstream Workflow

The results of the pituitary MRI will dictate the subsequent clinical pathway, which almost always involves close collaboration with an endocrinologist and potentially a neurosurgeon.

  • Positive for a Macroadenoma or Other Sellar Mass: If the MRI identifies a tumor causing mass effect on the optic chiasm or significant compression of normal structures, the next step is typically a referral to neurosurgery for consideration of surgical resection. A formal visual field examination by an ophthalmologist is also mandatory. The patient will require ongoing management by endocrinology for hormone replacement therapy both before and after any intervention.
  • Negative or Incidental Finding: If the MRI is normal or shows only a small, non-compressive incidental finding (e.g., a microadenoma <1 cm, a small Rathke's cleft cyst), the focus remains on endocrinological management. The cause of hypopituitarism may be idiopathic, congenital, or the result of a prior insult not visible on imaging. The primary task is careful hormone replacement and monitoring.
  • Findings Suggestive of Hypophysitis: If the MRI shows a thickened, enhancing stalk or diffuse glandular enlargement, the workup shifts toward identifying a systemic inflammatory or autoimmune cause. This may involve further serologic testing for conditions like sarcoidosis or IgG4-related disease and often requires a multidisciplinary discussion, as management may involve immunosuppressive therapy rather than surgery.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for hypopituitarism requires careful attention to clinical and imaging details. Common pitfalls include:

  • Ordering a “Brain MRI” Instead of a “Sella MRI”: A routine brain MRI protocol uses thicker slices and may not include the high-resolution, thin-slice dynamic contrast-enhanced sequences necessary to properly evaluate the pituitary. Always specify “MRI of the sella/pituitary with and without contrast.”
  • Misinterpreting an Incidentaloma: Small, non-functioning pituitary adenomas are common incidental findings in the general population. It is critical to correlate the imaging finding with the specific pattern of hormone deficiency to ensure the incidentaloma is the true cause.
  • Overlooking the Pituitary Stalk: The pituitary stalk is a key structure. A thickened, enhancing stalk should raise immediate suspicion for an inflammatory or infiltrative process like hypophysitis or sarcoidosis, steering the workup away from a simple adenoma pathway.
  • Forgetting Visual Field Testing: For any lesion abutting or compressing the optic chiasm, formal ophthalmologic evaluation with visual field testing is mandatory, regardless of whether the patient reports visual symptoms.

If the clinical picture and imaging findings are discordant, or if a complex diagnosis like hypophysitis is suspected, escalation to a subspecialist endocrinologist or a multidisciplinary pituitary conference is the appropriate next step.

Related ACR Topics and Tools

This article focuses on a single, specific clinical scenario. For a comprehensive overview of all related variants, from hyperfunctioning adenomas to pituitary apoplexy, please consult our parent guide. For additional resources to refine your imaging orders and discuss them with patients, the following tools are available.

Frequently Asked Questions

Why is a dedicated ‘MRI sella’ protocol necessary instead of a standard ‘MRI brain’?

A dedicated MRI of the sella (or pituitary) uses high-resolution, thin-slice imaging (typically 2-3 mm) focused on the sella turcica. It also includes a specific dynamic contrast-enhanced sequence where images are acquired rapidly after contrast injection to visualize the differential enhancement between the normal pituitary gland and an adenoma. A standard brain MRI uses thicker slices and different timing, which can easily miss small pituitary lesions or mischaracterize larger ones.

What if my patient has a contraindication to gadolinium contrast, like severe kidney disease?

In cases of a valid contraindication to gadolinium, the ACR still rates ‘MRI sella without IV contrast’ as ‘Usually appropriate.’ A non-contrast study can still identify macroadenomas, empty sella, cysts, and hemorrhage. While it is less sensitive for small microadenomas and inflammatory conditions like hypophysitis, it remains a highly valuable diagnostic tool and is superior to CT in this setting.

The MRI report mentions a ‘pituitary microadenoma.’ Does this automatically explain the patient’s hypopituitarism?

Not necessarily. Pituitary microadenomas (<10 mm) are common incidental findings in up to 10-20% of the general population and rarely cause hormone deficiencies through mass effect. If a patient has panhypopituitarism, a tiny microadenoma is an unlikely culprit. The cause may be idiopathic or related to another process. The clinical and biochemical picture must be carefully correlated with the imaging findings.

Is CT ever the first-choice imaging study for suspected hypopituitarism?

No, MRI is always the preferred initial study due to its superior soft-tissue resolution. CT is considered a second-line option, rated ‘May be appropriate,’ and is reserved for situations where MRI is absolutely contraindicated (e.g., patient has an incompatible pacemaker or severe claustrophobia precluding MRI) or is not available in a timely manner.

The patient’s symptoms are severe. Should I order an MRA or CTA to look for an aneurysm?

For the workup of hypopituitarism, dedicated vascular imaging like MRA or CTA is ‘Usually not appropriate.’ While a large parasellar aneurysm can rarely cause pituitary dysfunction by mass effect, this would typically be well-visualized on the standard post-contrast sequences of a dedicated pituitary MRI. Ordering a separate MRA or CTA as the initial study is not indicated unless there is a specific clinical suspicion for a vascular lesion independent of the hypopituitarism.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026